Sep 28, 2024, 16:29
Thor Halfdanarson: A good review for those encountering patients with t-MN
Thor Halfdanarson, Vice President at North American Neuroendocrine Tumor Society, shared the following insights about a paper by Sangeetha Venugopal and Amy E. DeZern, on X:
“Although there is little discussion of PRRT and therapy-related myeloid neoplasms, t-MN (MDS and AML) in here, this is a very good review for all who may encounter patients with t-MN or just want to know more about it.”
Therapy-Related Myelodysplastic Syndromes and Acute Myeloid Leukemia
Authors: Sangeetha Venugopal, Amy E. DeZern.
Source: Thor Halfdanarson/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 10, 2024, 08:54
Oct 10, 2024, 07:54
Oct 10, 2024, 07:51
Oct 10, 2024, 07:33
Oct 10, 2024, 06:41